Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
Julio García‐Aguilar, Lindsay A. Renfro(Mayo Clinic in Arizona), Oliver S. Chow(Memorial Sloan Kettering Cancer Center), Qian Shi(Mayo Clinic in Arizona), Xiomara W. Carrero(Mayo Clinic in Arizona), Patricio B. Lynn(Memorial Sloan Kettering Cancer Center), Charles R. Thomas(Oregon Health & Science University), Emily Chan(Vanderbilt University Medical Center), Peter A. Cataldo(University of Vermont), Jorge Marcet(Tampa General Hospital), David Medich(University of Pittsburgh Medical Center), Craig S. Johnson(St. Francis Hospital), Samuel Oommen(John Muir Medical Center), Bruce G. Wolff(Mayo Clinic in Arizona), Alessio Pigazzi(University of California, Irvine), Shane McNevin, Roger K Pons, Ronald Bleday(Brigham and Women's Hospital)
Cited by 422Open Access